Dinsmore Christopher 4
4 · Kronos Bio, Inc. · Filed Sep 9, 2021
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Dinsmore Christopher
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-09-07$21.91/sh−9,189$201,302→ 96,360 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-09-07−9,189→ 324,497 totalExercise: $3.27Exp: 2030-06-14→ Common Stock (9,189 underlying) - Exercise/Conversion
Common Stock
2021-09-07$3.27/sh+9,189$30,048→ 105,549 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- [F2]The weighted average sale price for the transaction reported was $21.9068, and the range of prices were between $20.85 and $22.78. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]Immediately exercisable.